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Introduction
MicroRNAs (miRNAs), typically 18-25 nucleotides long, constitute a class of small noncoding single-stranded RNAs (ssRNAs) that are highly conserved and endogenously expressed across many species. These miRNAs regulate gene expression by targeting complementary sequences primarily located within the 3'untranslated regions (UTRs) of mRNAs [1] [2] [3] [4] [5] [6] . Although the full extent of miRNA biological functions have yet to be elucidated, they have been suggested to function as intrinsic regulators of many cellular processes, including cell invasion, differentiation, proliferation and apoptosis [7] [8] [9] [10] [11] . The aberrant expression of miRNAs has been linked to the development and progression of several cancers and was shown to have prognostic significance for certain types of cancer, such as lung and esophageal cancer, neuroblastoma and lymphocytic leukemia [12] [13] [14] .
The altered expression miRNAs has previously been observed in esophageal cancer (EC), a major cause of cancer-related death worldwide [15] [16] [17] [18] . This observation indicates that the deregulation of miRNAs may play a role in the carcinogenesis of EC. Presently, the effects of miR-499 on the apoptosis and the metastasis of EC cells are not exactly elucidated.
Human DNA polymerase β (DNA polymerase β, polβ), a small monomeric protein of 335 residues, is found in the nuclei of mammalian cells [19] . Polβ, a member of the DNA polymerases family, is essential for short-patch base excision repair (BER) [20] [21] [22] . BER is one of the major pathways of DNA repair that repairs DNA damage caused by oxidation [23] . Polβ is also involved in the meiotic recombination [24] and the repair of breaks in doublestranded DNA through the process of nonhomologous end joining [25] . There are also studies that have revealed that polβ plays an important role in DNA single-strand breaks (SSB) resulting from rays and akylating agents [26] [27] [28] . Polβ expression is increased in many cancer cells [29] . More specifically, the overexpression of polβ results in aneuploidy and tumorigenesis in nude immunodeficient mice [30] . Moreover, polβ heterozygous mice exhibit increased single-stranded DNA breaks, chromosomal aberrations, and mutagenicity compared to normal animals [31] . Based on bioinformatic analyses we hypothesized that human polβ 3'UTR contains the putative binding sites of miR-499, and then miR-499 could enhance the cisplatin sensitivity of EC cell lines by targeting polβ.
In the present study, we first investigated whether miR-499 modulates polβ, and then observed the influence of miR-499 up-regulation on EC cell lines' sensitivity to cisplatin.
Materials and Methods
Cell culture
Human EC cell lines (EC9706 and KYSE30) were purchased from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, China). Both cell lines were maintained in RPMI 1640 with 10% fetal bovine serum (FBS; Gibco BRL, Gaithersburg, MD, USA) and incubated at 37°C/5% CO 2 .
Luciferase reporter assay
The human polβ 3'UTR fragment containing putative binding sites for miR-499 was amplified by PCR from human genomic DNA. The mutant polβ 3'UTRs were obtained by overlap extension PCR. The fragments were cloned into a pmirGLO reporter vector (Promega, Madison, WI, USA), downstream of the luciferase gene, in order to generate the recombinant vectors pmirGLO-WT and pmirGLO-MUT. For the luciferase reporter assay, EC9706 and KYSE30 cells were trypsinized and resuspended in PBS for electroporation with BTX ECM 2001 electroporator. Then 5 × 10 6 cells of each group were mixed with miRNA (miR-499 agomir or scrambled-miR-499 negative control; GenePharma, Shanghai, China) and reporter vectors (pmirGLO-WT reporter vectors or pmirGLO-MUT reporter vectors), and were electroporated with square pulse condition. Electroporated cells were incubated in 2 ml RPMI 1640 supplemented with 10% FBS for 24 hour. Luciferase activities were measured with a Dual-Luciferase assay kit (Promega, Madison, WI, USA) according to the manufacturer' s instructions, at 24h post-transfection. Experiments were repeated three times. RNA was extracted using the Total RNA Kit I (R6834-01; Omega) from the aforementioned three groups of cells. Approximately 1 μg of total RNA were used for the reverse transcriptase (RT)-PCR with (0.5 μg) oligo (dt) primer for first strand synthesis to generate cDNA. Next, the cDNAs were amplified using the following primers:
RNA isolation and RT-PCR
Polβ upstream: 5' GTGCAGAGTCCAGTGGTGACA 3'; Polβ downstream: 5' CAGTTTTGGCTGTTTGGTTGATT 3'; β-actin upstream: 5' TTCACTTCTTCAGTTCTGCCATCT 3'; β-actin downstream: 5' CCAAGCTTTTCTCAGTCCCATAA 3'.
The following thermal cycling conditions were used: denaturation at 94°C for 5 min followed by 36 cycles of denaturation at 94°C for 35 s, annealing at 56°C for 30 s, and extension at 72°C for 35 s. PCRamplified fragments were separated on a 1.5 % agarose gel.
Western blot assay
Total proteins from the three groups of transfected cells (Blank, NC and miR-499) were extracted using a RIPA buffer containing phenylmethanesulfonyl fluoride (PMSF). A BCA protein assay kit (Beyotime, Haimen, China) was used to determine the protein concentrations. Proteins were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and were later transferred onto polyvinyl difluoride (PVDF) membranes. After blocking, the membranes were incubated overnight at 4°C with diluted (1:300) primary antibody (polyclonal rabbit anti-polβ; Santa Cruz, USA). Following extensive washes, the membranes were incubated with diluted (1:3000) horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa Cruz). Signals were determined using the DAB detection kit (Amersham Pharmacia Biotech, Piscataway, NJ, USA). β-tubulin (Santa Cruz, USA) served as the endogenous reference.
Cell growth assay
Cell growth assay was performed using a cell counting kit-8 (CCK-8; Dojindo, Kumamoto, Japan) according to the manufacturer's instructions. The three groups of cells (Blank, NC and miR-499) were seeded into a 96-well plate at a density of 1 × 10 4 cells/well, with six replicate wells per group. Next, the cells were respectively treated with 2ìM cisplatin (Sigma-Aldrich, UK; dissolved in 0.15M NaCl, stored at -20°C) during the logarithmic growth phase. After cells were cultured for four consecutive days, the optical density (OD) was measured at a wavelength of 450 nm (OD 450 ) to estimate viable cell numbers. The cell survival rate was calculated according to the absorbance value inferred from living cell numbers in each of the three different treatment groups.
Colony-forming survival assay
The three groups of cells (Blank, NC and miR-499) were respectively treated with six different concentration cisplatin (0ìM, 2ìM, 4ìM, 6ìM, 8ìM and 10ìM) for 2 h during the logarithmic growth phase. Then the cells were washed, trypsinized, counted and plated into 10-cm dishes containing DMEM supplemented with 10% FBS, at a plating number of 200 cells per dish. The formation of colonies, usually occurring in approximately two weeks, could be visibly observed. The newly formed colonies were fixed with ethanol and stained with crystal violet, and the colonies with >50 cells were scored as surviving colonies [32, 33] . The cloning efficiency was calculated by dividing the average number of colonies per dish by the amount of cells plated.
In vivo tumor growth assay
The three groups of EC9706 cells (Blank, NC and miR-499) were respectively transfected with a luciferase-expressing lentivirus containing an independent open-reading frame of GFP. After 72 h, cells were examined by fluorescence microscopy to confirm infection. Then the EC9706-Luc cells (5 × 10 6 cells) were subcutaneously inoculated into the armpit of right forelimb of 6-week-old female BALB/c nude mice purchased from The Laboratory Animal Unit of the University of Zhengzhou. All three groups (6 mice per group) were intraperitoneally (i.p.) treated with 2 mg/kg cisplatin weekly for 4 weeks. Before the mice were anesthetized with Forane, an aqueous solution of luciferin (150 mg/kg) was intraperitoneally injected at 10 min prior to imaging. The mice were placed into the light-tight chamber of a CCD camera system
Results
Polβ is identified as a target gene of miR-499 in EC9706 and KYSE30 cell lines
Bioinformatics analysis by TargetScan and miRanda predicted that the 3'UTR of polβ contained binding sites for miR-499 (Fig. 1A) .
To verify whether polβ is a direct target of miR-499, we first used a Dual-Luciferase reporter system containing either the wild-type or the mutant 3'UTR of polβ. Co-transfection with miR-499 significantly suppressed the luciferase activity of the reporter containing the wild-type 3'UTR (P < 0.05, Fig. 1B) . Our results indicate that miR-499 negatively regulates polβ expression by directly binding to the putative binding sites in the 3'UTR.
RT-PCR and western blot assays were employed to detect the expression levels of polβ mRNA and protein after transfection with miR-499 agomir in EC9706 and KYSE30 cells. The expression level of polβ protein in the miR-499 group was found to be significantly lower (P < 0.05, Fig. 1C ) than in the Blank and NC groups. However, there were no significant differences in polβ mRNA expression levels among the three groups (P > 0.05, Fig. 1D ).
MiR-499 enhanced the proliferation inhibition effect of cisplatin in EC9706 and KYSE30 cells
The levels of miR-499 after transfection in EC9706 and KYSE30 cells are shown in Figure  2A . Expression levels of miR-499 in the miR-499 group were significantly higher (P < 0.05, Fig. 2A ) than in the Blank and NC groups.
The cell survival rate curves are presented in Fig. 2A . Cell viability decreased with increased chemotherapy dose. The miR-499 group's viability declined more significantly, and the decline has statistical differences with the Blank and NC groups at different chemotherapy doses (P < 0.05, Fig. 2B ). The t-test showed that there were no significant differences in cell 
Discussion
EC is a major cause of cancer-related death worldwide. Each year, approximately 30 million people worldwide die from esophageal cancer. Although the diagnosis and treatment of EC have advanced, the disease progresses quickly and has a poor prognosis caused by invasion and early stage metastasis [34, 35] . Due to the potential difficulties an operation would impose on both the patient and the surgeon, most advanced patients choose to undergo palliative treatments instead. Chemotherapy is one of the main palliative treatments of EC. However, the clinical efficacy of chemotherapy is not satisfactory, as evidenced by a 5-year survival rate of only 10-30% and a local tumor uncontrolled rate and recurrence rate reaching up to 60-80% [36, 37] . Therefore, improving the efficacy of chemotherapy is the current focus of researchers. In recent years, some reports have found a variety of genes whose expression products can affect tumor chemotherapy; examples include cell cycle regulatory genes, apoptotic genes, and DNA damage repair proteins [38] [39] [40] .
The DNA damage repair system exists in all cells, and has been demonstrated to be an important mechanism leading to the tumor cell's resistance or insensitivity to chemotherapy. Polβ is a key enzyme in the DNA damage repair system. This system serves as a crucial factor in maintaining genome integrity and stability, in addition to modulating the chemotherapy sensitivity of tumor cells. Not surprisingly, polβ has become a research hot spot worldwide.
miRNAs have been estimated to regulate up to 30% of human genes and control a variety of cellular processes [15, 41] . Recent studies have shown that miRNAs are dysregulated in various cancers, and that their expression is relevant to a diverse array of tumors [42] [43] [44] [45] .
In this study, we conducted a variety of assays including the luciferase reporter, RT-PCR and western blot. Through these assays we found that miR-499 could bind to the putative binding sites within the polβ mRNA 3'UTR and thereby reduce the expression of polβ. We also discovered that miR-499 could inhibit the proliferation, induce the apoptosis and decrease, the DNA repair capacity of EC cell lines by targeting polβ. Furthermore, using the CCK-8,
